Medical Condition News

RSS

Study successfully identifies ways to manipulate mitoNEET protein

Researchers at UT Southwestern Medical Center have taken another step toward better understanding the metabolic functions of obesity and its connection to type 2 diabetes.

17 Dec 2012

First meta-analytic review of association of perceived stress and incident CHD

Are you stressed? Results of a new meta-analysis of six studies involving nearly 120,000 people indicate that the answer to that question may help predict one's risk of incident coronary heart disease (CHD) or death from CHD.

17 Dec 2012

Study sheds light on how new treatments could be more effective in early stages of bipolar disorder

A North West clinical trial of people who have been diagnosed with bipolar disorder for less than five years will be the first study of its kind to shed light on how new treatments could be more effective in the early stages of the condition.

17 Dec 2012

Osteoporosis screening: an interview with Professor Cyrus Cooper

Osteoporosis is defined as a reduction in bone mass coupled with micro-architectural deterioration of bone tissue which predisposes to fractures. Osteoporosis manifests through an increased risk of fracture, and age-related fractures are a major public health problem.

17 Dec 2012

New report provides snapshot of Canada's cancer system

A comprehensive report released today by the Canadian Partnership Against Cancer provides a snapshot of how Canada's cancer system is performing in key areas from prevention through to patient experience and outcomes.

17 Dec 2012

NeoGenomics launches FISH assay for surveillance of patients with Barrett's Esophagus

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today it has validated and launched a laboratory developed Fluorescent in Situ Hybridization assay for the surveillance of patients with Barrett's Esophagus.

17 Dec 2012

Lexicon receives FDA Fast Track status for development of LX1033 for irritable bowel syndrome

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has received "Fast Track" status from the U.S. Food and Drug Administration for the development of LX1033, an orally-delivered small molecule drug candidate for diarrhea-predominant irritable bowel syndrome (IBS-d).

17 Dec 2012

Allakos closes $32M Series A financing to develop antibody-based therapeutics

Allakos Inc. announced today that it has completed a $32 million Series A preferred stock financing led by Novo Ventures with participation from Alta Partners, RiverVest Venture Partners and the Roche Venture Fund. Peter Moldt , PhD., Partner at Novo Ventures, Robert Alexander , PhD., Director at Alta Partners and John McKearn PhD., Managing Director at RiverVest Venture Partners, will join the Board of Directors.

17 Dec 2012

ProMining Therapeutics, Roche to develop small molecule therapeutics for type 2 diabetes mellitus

ProMining Therapeutics, Ltd. today announced a new collaboration with Roche in the field of type 2 diabetes mellitus.

17 Dec 2012

New research reveals music's health benefits

Music has been incorporated into medical practice since before the ancient Greeks. However, though practitioners have been convinced of music's health benefits for thousands of years, there had been little peer-reviewed research to back them up. But recent studies are providing an empirical backbone for the anecdotal evidence.

17 Dec 2012

UMCG enrolls and treats first patients in RENEW pivotal trial to evaluate RePneu LVRC

PneumRx, Inc., a leader in interventional pulmonology, announced today that University Medical Center Groningen has enrolled and treated the first patients in the FDA-approved RENEW pivotal trial to evaluate the RePneu Lung Volume Reduction Coil.

17 Dec 2012

First Edition: December 17, 2012

Today's headlines include weekend updates regarding the fiscal cliff negotiations as well as news regarding states' decisions on health exchanges.

17 Dec 2012

Scientists develop new nanotechnology to capture, release tumor cells that circulate in bloodstream

Scientists from the RIKEN Advanced Science Institute in Japan and University of California Los Angeles report a new nanoscale Velcro-like device that captures and releases tumor cells that have broken away from primary tumors and are circulating in the bloodstream.

17 Dec 2012

GTx achieves enrollment goal for pivotal Phase III clinical studies of enobosarm

GTx, Inc. today announced that it has attained its enrollment goal for both of its pivotal Phase III clinical studies of enobosarm to prevent and treat muscle wasting in non-small cell lung cancer patients.

17 Dec 2012

Dyslipidaemia: an interview with Prof. Peter Kokkinos

Dyslipidemia is defined as abnormal levels of blood lipids (fats) and cholesterol. The most common dyslipidaemias are high blood cholesterol (Total Cholesterol) and triglyceride levels, high levels of low-density lipoprotein (LDL) cholesterol (‘bad’ cholesterol) and low levels of high-density lipoprotein (HDL) cholesterol (‘good’ cholesterol).

17 Dec 2012

Loading up on snack foods may increase cancer risk in individuals with Lynch syndrome

A new analysis has found that loading up on snack foods may increase cancer risk in individuals with an inborn susceptibility to colorectal and other cancers. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that an eating pattern low in snack foods could help these individuals-who have a condition called Lynch syndrome-lower their risk.

17 Dec 2012

New technique could help develop more-specific, cell-based immune therapies for cancer

A team led by Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering at Memorial Sloan-Kettering Cancer Center, has shown for the first time the effectiveness of a new technique that could allow the development of more-specific, cell-based immune therapies for cancer.

17 Dec 2012

Blocking single tiny blood vessel in the brain can harm neural tissue and even alter behavior

Blocking a single tiny blood vessel in the brain can harm neural tissue and even alter behavior, a new study from the University of California, San Diego has shown. But these consequences can be mitigated by a drug already in use, suggesting treatment that could slow the progress of dementia associated with cumulative damage to miniscule blood vessels that feed brain cells.

17 Dec 2012

Immunohistochemistry reliable in identifying ALK rearrangement: Study

Favorable results have led to crizotinib gaining approval for the treatment of advanced stage ALK-positive non-small cell lung cancer (NSCLC) in Japan, the United States, Canada, and several other countries in Europe and Asia.

17 Dec 2012

Three critical illness factors independently associated with increased risk of dementia

Older people often worry about dementia and while some risks are known, for example alcoholism or stroke, the effects of illness are less clear. New research published in BioMed Central's open access journal Critical Care looks at illness requiring hospitalization and treatment in the intensive care unit (ICU) and finds that infection or severe sepsis, neurological dysfunction, such as delirium, or acute dialysis are all independently associated with an increased risk of a subsequent diagnosis of dementia.

17 Dec 2012

Medical Condition News

Study successfully identifies ways to manipulate mitoNEET protein

First meta-analytic review of association of perceived stress and incident CHD

Study sheds light on how new treatments could be more effective in early stages of bipolar disorder

Osteoporosis screening: an interview with Professor Cyrus Cooper

New report provides snapshot of Canada's cancer system

NeoGenomics launches FISH assay for surveillance of patients with Barrett's Esophagus

Lexicon receives FDA Fast Track status for development of LX1033 for irritable bowel syndrome

Allakos closes $32M Series A financing to develop antibody-based therapeutics

ProMining Therapeutics, Roche to develop small molecule therapeutics for type 2 diabetes mellitus

New research reveals music's health benefits

UMCG enrolls and treats first patients in RENEW pivotal trial to evaluate RePneu LVRC

First Edition: December 17, 2012

Scientists develop new nanotechnology to capture, release tumor cells that circulate in bloodstream

GTx achieves enrollment goal for pivotal Phase III clinical studies of enobosarm

Dyslipidaemia: an interview with Prof. Peter Kokkinos

Loading up on snack foods may increase cancer risk in individuals with Lynch syndrome

New technique could help develop more-specific, cell-based immune therapies for cancer

Blocking single tiny blood vessel in the brain can harm neural tissue and even alter behavior

Immunohistochemistry reliable in identifying ALK rearrangement: Study

Three critical illness factors independently associated with increased risk of dementia

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News